高级搜索

15例恶性胸腺瘤化疗临床总结

刘鹏, 张湘茹, 冯奉仪

刘鹏, 张湘茹, 冯奉仪. 15例恶性胸腺瘤化疗临床总结[J]. 肿瘤防治研究, 1999, 26(6): 439-441.
引用本文: 刘鹏, 张湘茹, 冯奉仪. 15例恶性胸腺瘤化疗临床总结[J]. 肿瘤防治研究, 1999, 26(6): 439-441.
A Study of Chemotherapy for Malignant Thymoma on 15 Patients[J]. Cancer Research on Prevention and Treatment, 1999, 26(6): 439-441.
Citation: A Study of Chemotherapy for Malignant Thymoma on 15 Patients[J]. Cancer Research on Prevention and Treatment, 1999, 26(6): 439-441.

15例恶性胸腺瘤化疗临床总结

A Study of Chemotherapy for Malignant Thymoma on 15 Patients

  • 摘要: 目的 评价恶性胸腺瘤不同化疗方案的选择与疗效间的关系。 方法 本文回顾性总结T1978-1997年12月间15例晚期恶性胸腺瘤患者接受化疗的资料,其中接受含DDP方案7例,不含DDP方案8例。 结果 总有效率(RR)20%(3/15),中位生存期14个月:其中接受含DDP方案者RR0,中位生存期9.5个月;接受不含DDP方案者RR37.5%中位生存期14个月,P<0.05。 结论 含顺铂方案治疗恶性胸腺瘤在疗效上及患者生存时间上并不优于不含顺铂方案。
    Abstract: Objective To evaluate the effects of different chemotherapeutic projects on malignant thymoma. Methods The retrospective study summarized the data of 15 cases of phase Ⅲ.Ⅳ malignant thymoma from 1978 to Dec.1997. Results There was 0/7 RR in the group with cisplatin, the MTS were 9.5 months,while 3/8 RR in the other group without cisplatin,the MTS was 14 months;and the overall response rate was 20%,while the MTS was 14 months.There is statistical difference in rsponse between the two groups (P<0.05). Conclusion The chemotherapy with cisplatin did not get better of the chemotherapy without cisplatin in comparison of effect and survival time.
  • 1 汪良骏,汪相.纵隔肿瘤.谷铣之主编.现代肿瘤学(临床部分).第1版.北京:北京医科大学中国医科大学联合出版社,1993
    2 Verley JM, Holltr}aru} KH: 7lirtarna. A cormparative study dclinical stages,histologic features,and survival in 200 cases.Cancer,1985,55: 1074~1086
    3 Magi G, Giaccone G, Donadio M, et al.Thycnaes, a reviewd 1691 986,58:765一776
    4 Marks RD, Wallace KM, Pettit HS: Radiation therapy control of nine patients with malignant thynnonu. Cancer, 1978,41:117一l19
    5 Penn RH, Hope-Stone HF:The role of radiotherapy in the mmagment of malignant thymoma. Br J Surg 1972,59:553一538
    6 Bonomi PD, Finkelstein D, Aisner S, Ettinger D: EST 2582 phase Qtrial of Cisplatin in melastatic or recurrent thyrnana..4m J Clin Oncol, 1993,16:342一345
    7 Rosenberg JC: Neopla_sms of the Mediastinum. Cancer 3 Edition, 1992 8 Ioelrrer PJ:Thymomas, Current Mecperience and future directions in therapy.Dnrgs,1993,45:477一487
    9 Fomasiero A, Daniele 0, Ghiotto C, et al. Chemotherapy for invasive thymmia:a 13-year experience.Cancer,1991,68:30一3310 Bjemrm OW. mss K, Daugaard G. Combination chert}otherapy with a Five-Drug Regimen for invasive thymorna. Acta Oncoloeca, 1996, 35:7l一73
    11 Giacaxre G, Ardiaoni A, Kirkpatrick A, et al. Cisplatin and Etoposide Combination Chemotherapy for Locally Advanced or Mertastatic Thymoma:.4 phase Q study of the European Organisation for Research and Treatment of Cancer (EORTC)lyng Cancer Cooperative Gmup.J Clin Onco1,1996,14:814一820
    12 Loehrer PJ, Kim KM, Aisner SC, et al. Cisplatin plus doxorubicin plus cyclophospharttide in metastatic of recurrent thyrrama: Final results of an intergroup trial.J Clin Oncol,1994,12:1164一1168
    13 Park HS, Shin DM, Lee JS, et al.Ihymoma.4 retrospective study of 87 cases.Cancer,1994,73:2491一2.498
    14 Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thywith special reference to their clinical stages. Cancer,1981,48:2485一2492
计量
  • 文章访问数:  1984
  • HTML全文浏览量:  42
  • PDF下载量:  333
  • 被引次数: 0
出版历程
  • 刊出日期:  1999-12-04

目录

    冯奉仪

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索

    /

    返回文章
    返回
    x 关闭 永久关闭